华东数控(002248) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was ¥70,857,273.85, representing a 106.62% increase compared to ¥34,292,937.95 in the same period last year[8] - Net profit attributable to shareholders was ¥4,989,457.31, a significant turnaround from a loss of ¥9,514,095.91 in the previous year, marking a 152.44% improvement[8] - Basic earnings per share improved to ¥0.02 from a loss of ¥0.03, reflecting a 166.67% increase[8] - Operating profit turned positive at ¥4,662,779.64 compared to a loss of ¥11,190,912.44 in the same period last year[39] - Net profit reached ¥4,681,514.68, a significant recovery from a net loss of ¥11,287,653.58 in the previous year[39] - The company achieved a total comprehensive income of ¥4,681,514.68, recovering from a loss of ¥11,287,653.58[39] Cash Flow - The net cash flow from operating activities reached ¥11,060,898.29, up 334.85% from a negative cash flow of ¥4,709,765.94 in the prior year[8] - Cash inflow from operating activities totaled ¥39,338,417.16, up from ¥14,388,589.66 in the previous period, reflecting a growth of approximately 173%[46] - The net cash flow from operating activities was ¥15,574,052.93, a significant improvement compared to the previous period's net cash flow of -¥6,831,466.80, indicating a turnaround in operational performance[46] - The company experienced a net decrease in cash and cash equivalents of ¥21,558,704.87, an improvement from the previous period's decrease of ¥48,034,926.61[46] Assets and Liabilities - Total assets at the end of the reporting period were ¥504,418,323.07, a decrease of 2.82% from ¥519,030,046.89 at the end of the previous year[8] - Total liabilities decreased to ¥449,440,420.73 from ¥469,054,697.25, a reduction of 4.3%[33] - The company's short-term borrowings decreased to ¥120,000,000.00 from ¥150,000,000.00, a decrease of 20%[33] - Long-term payables surged by 276.70% to ¥44,993,160.23 from ¥11,943,957.23, due to received equipment relocation compensation[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,991[12] - The largest shareholder, Weihai Weigao International Medical Investment Holding Co., Ltd., holds 17.50% of the shares, totaling 53,825,800 shares[12] - Net assets attributable to shareholders increased by 10.97% to ¥53,727,974.08 from ¥48,417,478.75 at the end of the last year[8] Operating Costs and Expenses - Operating costs rose to ¥57,794,624.34, reflecting an 89.22% increase from ¥30,544,410.93, in line with the substantial revenue growth[16] - The company’s sales expenses increased by 46.54% to ¥3,887,765.02, up from ¥2,653,110.42, reflecting higher costs associated with increased sales activities[16] - The company’s financial expenses decreased by 31.26% to ¥1,707,485.32 from ¥2,484,085.42, attributed to a reduction in borrowing scale[16] - The company reported a significant reduction in financial expenses, with interest expenses decreasing to ¥1,733,002.74 from ¥2,747,434.73[39] Investment Activities - The net cash flow from investment activities was ¥19,879,803.00, a recovery from the previous period's net cash flow of -¥29,644,578.34, indicating a positive shift in investment returns[46] Future Outlook - The company plans to continue focusing on market expansion and product development to sustain growth momentum[39]